SEC Form 4 · accession 0001144204-18-055210
ENDRA Life Sciences Inc. · NDRA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Period of report
Oct 22, 2018
Accepted (ET)
Oct 24, 2018 · 8:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001681682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Oct 22, 2018 | S | 50,200 | $4.1649 | D | 379,237 | I | See footnote |
| Common StockF1 | Oct 23, 2018 | S | 50,000 | $4.2177 | D | 329,237 | I | See footnote |
| Common StockF2 | Oct 24, 2018 | S | 30,000 | $4.1761 | D | 299,237 | I | See footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Longboard Capital Advisors, LLC is the Investment Manager of Grayboard Investments, Ltd. Grayboard Investments Ltd. sold 100,200 shares of Common Stock in Endra Life Sciences, Inc. Grayboard Investments, Ltd. now owns 110,338 shares of Common Stock in Endra Life Sciences, Inc.
- F2Longboard Capital Advisors, LLC is the General Partner of Blue Earth Fund, LP. Blue Earth Fund, LP sold 30,000 shares of Common Stock in Endra Life Sciences, Inc. Blue Earth Fund, LP now owns 188,899 shares of Common Stock in Endra Life Sciences, Inc. The total amount of Common Stock owned by Blue Earth Fund, LP is Grayboard Investments, Ltd. and Blue Earth Fund, LP is 299, 237. There was no change in the amount of Warrants to purchase Common Stock as previously reported.